Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.81709 | 63 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.20473 | 68 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.03443 | 67 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.87113 | 73 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.69612 | 73 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.27552 | 69 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.21485 | 68 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.0153 | 66 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.59427 | 72 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.36121 | 70 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.18997 | 68 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.18059 | 68 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.19819 | 68 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.03174 | 67 |